454 related articles for article (PubMed ID: 16996681)
1. In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 Apr; 248(2):321-31. PubMed ID: 16996681
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.
Deegan C; Coyle B; McCann M; Devereux M; Egan DA
Chem Biol Interact; 2006 Dec; 164(1-2):115-25. PubMed ID: 17030029
[TBL] [Abstract][Full Text] [Related]
3. A study of the role of apoptotic cell death and cell cycle events mediating the mechanism of action of 6-hydroxycoumarin-3-carboxylatosilver in human malignant hepatic cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 May; 250(1):128-39. PubMed ID: 17126993
[TBL] [Abstract][Full Text] [Related]
4. In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells.
Deegan C; McCann M; Devereux M; Coyle B; Egan DA
Cancer Lett; 2007 Mar; 247(2):224-33. PubMed ID: 16740357
[TBL] [Abstract][Full Text] [Related]
5. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
[TBL] [Abstract][Full Text] [Related]
6. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans.
Thati B; Noble A; Rowan R; Creaven BS; Walsh M; McCann M; Egan D; Kavanagh K
Toxicol In Vitro; 2007 Aug; 21(5):801-8. PubMed ID: 17350222
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Eur J Pharmacol; 2007 Aug; 569(1-2):16-28. PubMed ID: 17585902
[TBL] [Abstract][Full Text] [Related]
9. New zirconium (IV) complexes of coumarins with cytotoxic activity.
Kostova I; Momekov G
Eur J Med Chem; 2006 Jun; 41(6):717-26. PubMed ID: 16697491
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
11. Structure-cytotoxic activity relationships of simple hydroxylated coumarins.
Kawase M; Sakagami H; Hashimoto K; Tani S; Hauer H; Chatterjee SS
Anticancer Res; 2003; 23(4):3243-6. PubMed ID: 12926059
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
Zhang J; Li Y; Sun J
Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of Gd(III)- and Dy(III)-complexes.
Kostova I; Kiefer W; Momekov G
Arch Pharm (Weinheim); 2007 Dec; 340(12):642-9. PubMed ID: 17994606
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells.
Duff B; Thangella VR; Creaven BS; Walsh M; Egan DA
Eur J Pharmacol; 2012 Aug; 689(1-3):45-55. PubMed ID: 22705894
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of new neodymium (III) complexes of bis-coumarins.
Kostova I; Manolov I; Momekov G
Eur J Med Chem; 2004 Sep; 39(9):765-75. PubMed ID: 15337289
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
[TBL] [Abstract][Full Text] [Related]
20. Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.
Barreiro E; Casas JS; Couce MD; Sánchez A; Sordo J; Vázquez-López EM
J Inorg Biochem; 2014 Feb; 131():68-75. PubMed ID: 24269769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
